Login / Signup

Practical lessons from treating medullary thyroid carcinoma patients harboring a RET-alteration: Pralsetinib-induced acute confusional state.

Eliya ShacharShira Peleg HassonDeborah T BlumenthalMeerav FraenkelYoel UriIdo WolfSimona Grozinsky-Glasberg
Published in: Acta oncologica (Stockholm, Sweden) (2022)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • patient reported outcomes